Skip to main content
Premium Trial:

Request an Annual Quote

Lexogen Nabs Austrian Funding for RNA-Seq Coronavirus Test

NEW YORK – Lexogen announced Wednesday it has received funding from the Austrian government to develop an RNA sequencing-based COVID-19 diagnostic test for mass screening.

The funding was part of a €16 million ($17.4 million) disbursement from the Austria Research Promotion Agency to companies pursuing vaccines, therapeutics, and diagnostics for COVID-19. A Lexogen spokesperson declined to disclose the exact amount the firm received, but said "the amount granted is exactly what we asked for and it will allow us to develop the test according to the planned timeline, which is very soon given the urgency of having such test for the community."

The Vienna-based sample preparation firm will base its new test on its QuantSeq-Flex Targeted RNA-seq platform. The firm said in a statement the test will allow screening of tens of thousands of samples in parallel.

"Identifying the newly infected on a broad scale will allow us to isolate entire infection clusters at an early stage and help fight the present pandemic as well as reoccurring infection waves," Lexogen CEO and founder Alexander Seitz said in a statement. "It will also enable us to screen hospitals and retirement homes and test especially first responders and front-line workers on a daily basis, helping to keep these essential facilities open and safe."

Lexogen added it will also provide a test for tracking mutations in SARS-CoV-2, the virus that causes COVID-19.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.